Steven B. Ratoff's most recent trade in Eagle Pharmaceuticals Inc was a trade of 16,253 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 7, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eagle Pharmaceuticals Inc | Steven B. Ratoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 16,253 | 16,253 | - | - | Stock Option (right to buy) | |
| Eagle Pharmaceuticals Inc | Steven B. Ratoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 11,200 | 11,200 | - | - | Stock Option (right to buy) | |
| Eagle Pharmaceuticals Inc | Steven B. Ratoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.78 per share. | 08 Apr 2021 | 2,340 | 25,024 (0%) | 0% | 8.8 | 20,545 | Common Stock |
| Eagle Pharmaceuticals Inc | Steven B. Ratoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2021 | 2,340 | 0 | - | - | Stock Option (right to buy) | |
| Eagle Pharmaceuticals Inc | Steven B. Ratoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2021 | 2,340 | 0 | - | - | Stock Option (right to buy) | |
| Eagle Pharmaceuticals Inc | Steven B. Ratoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2021 | 2,340 | 0 | - | - | Stock Option (right to buy) | |
| Eagle Pharmaceuticals Inc | Steven B. Ratoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.42 per share. | 08 Apr 2021 | 2,340 | 27,364 (0%) | 0% | 4.4 | 10,343 | Common Stock |
| Eagle Pharmaceuticals Inc | Steven B. Ratoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.78 per share. | 08 Apr 2021 | 2,340 | 22,684 (0%) | 0% | 8.8 | 20,545 | Common Stock |
| Eagle Pharmaceuticals Inc | Steven B. Ratoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 13,500 | 13,500 | - | - | Stock Option (right to buy) |